Shares of generic drug makers have plunged in recent days, but here’s a steady growth-and-income gem that’s largely immune to the carnage. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Readers asked about social media risks, problematic defense contractor cash flows, the best pot investments, and energy sector indebtedness. Read More
Curb your enthusiasm! There’s still time to protect your portfolio against the downturn that’s likely to hit this year. Read More
The grandfather of social media stocks is dangerously overvalued and ripe for a fall. Read More
Marijuana isn’t just for pain treatment or recreation. It can help people kick nicotine. Here’s your best play on this surprising “canna-business” application. Read More
Britain is likely to fall on its face as it runs from the European Union. Here’s a way to make quick profits from the chaos. Read More
Readers weighed in about Chipotle’s food poisoning woes, Scana’s nuclear project hurdles, Smart Sand’s stock slump, and other topics. Read More
Trumpcare this week came back from the dead to narrowly survive a Senate vote. Here’s a health sector stock that should benefit, regardless of the bill’s ultimate fate. Read More
Readers asked about refining stocks, small-cap electronics firms, and the soaring fortunes of the world’s biggest aerospace manufacturer. Read More
This “fast casual” Mexican food chain continues to frustrate investors hoping that its stock will make a sustainable comeback. The latest food poisoning outbreak indicates that CMG still has a long way to go. Read More